IP Library Granted Patent US 7,252,812
Granted Patent B2
US 7,252,812 · App. 10/716,721 · Granted Aug 7, 2007

High-yield method of endohedrally encapsulating species inside fluorinated fullerene nanocages

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,252,812
App. No.
10/716,721
Granted
Aug 7, 2007
Kind
B2
Abstract

This invention is directed to the fluorination (or derivatization with alternative chemical species) of fullerene carbon nanocages as an efficient way to (a) facilitate synthesis of endohedral complexes by a significant reduction or elimination of the barriers for the entry of guest-ions, -atoms or molecules, and (b) to preserve the chemical stability of final product.

Claims (40)

1. A method comprising the steps of:

(a) covalently attaching species to the exterior of the fullerene carbon nanocage to form a derivatized fullerene carbon nanocage wherein the derivatized fullerene carbon nanocage is a fluorinated fullerene nanocage;

(b) inserting an endohedral doping agent into the derivatized fullerene carbon nanocage.

2. The method of claim 1 , wherein the step of inserting comprises breaking and subsequent reformation of carbon-carbon bonds in the fullerene nanocage structure.

3. The method of claim 1 , wherein the step of covalently attaching decreases the potential energy barrier for the step of inserting.

4. The method of claim 1 , wherein the fullerene carbon on nanocage is selected from the group consisting of fullerenes, buckyballs, carbon nanotube, nested fullerenes, bucky onions, single-wall carbon nanotubes, multi-wall carbon nanotubes carbon fibrils, and combinations thereof.

5. The method of claim 1 , wherein the endohedral doping agent is selected from the group consisting of a charged species, a neutral species, ion(s), atom(s), atom clusters, molecules, and combinations thereof.

6. The method of claim 5 , wherein the endohedral doping agent is radioactive.

7. The method of claim 5 , wherein the endohedral doping agent is inserted via ion bombardment.

8. The method of claim 5 , wherein the endohedral doping agent decays into a radioactive species.

9. The method of claim 1 , further comprising removing at least some of the covalently attached species from the exterior of the fullerene carbon nanocage after the step of inserting.

10. The method of claim 1 , further comprising adding bio-specific ligands or antibodies to the fullerene nanocage.

11. The method of claim 10 , wherein the step of adding occurs before the step of attaching.

12. The method of claim 10 , wherein the step of adding occurs during the step of attaching.

13. The method of claim 10 , wherein the step of adding occurs between the step of attaching and the step of inserting.

14. The method of claim 10 , wherein the step of adding occurs after the step of inserting.

15. A method comprising:

(a) derivatizing a fullerene with a fluorine specie; and

(b) endohedrally modifying the fullerene.

16. The method of claim 15 , wherein the fullerene is a fullerene tube.

17. The method of claim 16 , wherein the fullerene tube is a single-wall carbon nanotube.

18. The method of claim 17 , wherein the sidewall carbon nanotube is derivatized on the sidewall of the single-wall carbon nanotube.

19. A composition comprising:

(a) a fluorine-derivatized fullerene;

(b) a first species covalently attached to the fullerene; and

(c) a second species endohedrally located in the fullerene.

20. The composition of claim 19 , wherein the second species is selected from the group consisting of ions, atoms, molecules, and combinations thereof.

21. The composition of claim 19 , wherein the second species is radioactive.

22. The composition of claim 19 , further comprising a third species attached to the fullerene, wherein the third species is selected from the group consisting of bio-specific ligands, antibodies, and combinations thereof.

23. The composition of claim 19 , wherein, the first species is selected from that group consisting of bio-specific ligands and antibodies.

24. A composition comprising:

(a) fullerene carbon nanocage;

(b) a first species covalently attached to the fullerene carbon nanocage, wherein the first species covalently attached to the fullerene carbon nanocage is fluorine; and

(c) a second species endohedrally located in the fullerene carbon nanocage.

25. The composition of claim 24 further comprising a third species attached to the fullerene, wherein the third species attached to the fullerene carbon nanocage is selected from the group consisting of bio-specific ligands antibodies, and combination thereof.

26. The composition of claim 24 , wherein the second species endohedrally located in the fullerene carbon nanocage is a radioactive species.

27. The composition of claim 26 , wherein the radioactive species is selected from the group consisting of T + , T 2 , 3 He, cobalt isotopes or small ionic radius, and combinations thereof.

28. The composition of claim 24 , wherein the fullerene carbon nanocage is a fullerene cube.

29. The composition of claim 28 , wherein the fullerene tube is a single-wall carbon nanotube.

30. The composition of claim 29 , wherein the sidewall carbon nanotube is derivatized on the sidewall of the single-wall carbon nanotube.

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 19, 2011
From: RICE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 026776/0367 →
Continuity (6)
Continuation In Part 0978747300
Provisional Application 6042743100 · Nov 19, 2002
Provisional Application 6013850500 · Jun 10, 1999
Provisional Application 6010691800 · Nov 3, 1998
Provisional Application 6010109200 · Sep 18, 1998
Related Publication 20040258603A1 · Dec 23, 2004